Tarrytown, NY, United States of America

Tara Young

This inventor holds 1 USPTO granted patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tara Young. Retrieved from https://idiyas.com/inventor/tara-young-h1fdnmjk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tara Young: Innovator in Tumor Cell Sensitization

Introduction

Tara Young is a prominent inventor based in Tarrytown, NY (US). She has made significant contributions to the field of immunotherapy, particularly in the sensitization of tumor cells. Her innovative work has the potential to enhance the effectiveness of cancer treatments.

Latest Patents

Tara Young holds a patent titled "Methods and Compositions for Sensitization of Tumor Cells to Immune Therapy." This patent represents her groundbreaking research and development in improving cancer therapies. She has 1 patent to her name, showcasing her commitment to advancing medical science.

Career Highlights

Tara is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to work on innovative solutions in the pharmaceutical industry. Her role at Regeneron allows her to collaborate with other talented professionals and contribute to cutting-edge research.

Collaborations

Some of her notable coworkers include Christopher Daly and Gavin Thurston. Their collaboration fosters a dynamic environment for innovation and research, enhancing the potential for groundbreaking discoveries in their field.

Conclusion

Tara Young is a dedicated inventor whose work in tumor cell sensitization is paving the way for advancements in cancer treatment. Her contributions to Regeneron Pharmaceuticals, Inc. and her innovative patent reflect her commitment to improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…